SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-003980
Filing Date
2014-08-14
Accepted
2014-08-14 16:50:31
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081314.htm 10-Q 1107924
2 EXHIBIT 10.1 exh_101.htm EX-10.1 29162
3 EXHIBIT 10.2 exh_102.htm EX-10.2 40948
4 EXHIBIT 31.1 exh_311.htm EX-31.1 17080
5 EXHIBIT 31.2 exh_312.htm EX-31.2 17551
6 EXHIBIT 32.1 exh_321.htm EX-32.1 7479
7 EXHIBIT 32.2 exh_322.htm EX-32.2 7525
  Complete submission text file 0001171843-14-003980.txt   5355268

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tkmr-20140630.xml EX-101.INS 842035
9 XBRL TAXONOMY EXTENSION SCHEMA tkmr-20140630.xsd EX-101.SCH 37147
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tkmr-20140630_cal.xml EX-101.CAL 28892
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tkmr-20140630_def.xml EX-101.DEF 158539
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE tkmr-20140630_lab.xml EX-101.LAB 251723
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tkmr-20140630_pre.xml EX-101.PRE 161970
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 141043837
SIC: 2834 Pharmaceutical Preparations